EP0777716A2 - Surface-active formulations - Google Patents

Surface-active formulations

Info

Publication number
EP0777716A2
EP0777716A2 EP95929862A EP95929862A EP0777716A2 EP 0777716 A2 EP0777716 A2 EP 0777716A2 EP 95929862 A EP95929862 A EP 95929862A EP 95929862 A EP95929862 A EP 95929862A EP 0777716 A2 EP0777716 A2 EP 0777716A2
Authority
EP
European Patent Office
Prior art keywords
formulation according
component
weight
formulation
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95929862A
Other languages
German (de)
English (en)
French (fr)
Inventor
Laszlo Moldovanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba Spezialitaetenchemie Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba Spezialitaetenchemie Holding AG filed Critical Ciba Geigy AG
Publication of EP0777716A2 publication Critical patent/EP0777716A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0063Photo- activating compounds

Definitions

  • the present invention relates to surface-active formulations as well as to their use for the disinfection and cleansing of the human skin and hands and of hard objects.
  • the surface-active formulations comprise
  • Soap formulations will be understood as meaning aqueous soap solutions which may be obtained as soap or so-called syndet solutions (synthetic detergents).
  • the antimicrobial activity of the novel formulation reaches gram-positive and gram-negative bacteria as well as yeasts, dermatophytes and the like.
  • Suitable components (a) are preferably 2-hydroxydiphenyl ethers, 2-hydroxydiphenyl methanes and 2-hydroxydiphenyl thioethers of the general formula
  • X is oxygen, sulfur or -CH ,
  • Y is chloro or bromo
  • z is S0 2 H, N0 2 or Cj -C 4 alkyl
  • n O or 1.
  • X is oxygen, sulfur or -CH 2 -
  • Y is chloro or bromo
  • r 1 is or 2
  • Component (a) in the novel formulation is preferably used in amounts of 0.02 to 0.2% by weight.
  • C 3 -C 12 di- or polycarboxylic acids typically malonic, succinic, glutaric, adipic, pimelic, suberic, azelaic and sebacic acid, undecanecarboxylic and dodecanedicarboxylic acid, fumaric, maleic, tartaric and malic acid as well as citric and aconitic acid;
  • aminocarboxylic acids typically ethylenediaminetetracetic acid, hydroxyethyl- ethylenediaminetetracetic acid and nitrilotriacetic acid;
  • aromatic carboxylic acids typically benzyl, phenylacetic, phenoxyacetic and cinnamic acid, 2-, 3- and 4-hydroxybenzoic acid, anilinic acid as well as o-, m- and p-chlorophenylacetic acid and o-, m- and p-chlorophenoxyacetic acid;
  • amine salts Rj, R and R 3 have the meaning indicated above;
  • Rj is hydrogen or C ⁇ -C 12 alkyl
  • R 2 and R 3 are each independently of the other hydrogen, C r C 12 alkyl,
  • Rj, R 2 , R 3 and R 4 are each independently of one another hydrogen, Ci-Cgalkyl,
  • C 4 -C 18 aliphatic and monocyclic alcohols typically C -C 18 alkanols, C 2 -C 18 alkenols and teipene alcohols e.g. ethanol, propanol, isopropanol, hexanol, cis-3-hexene-l-ol, trans-2-hexene-l-ol, l-octen-3-ol, heptanol, octanol, trans-2-cis-6-nonadien-l-ol, decanol, linalol, geraniol, dihydroterpineol, myrcenol, nopol and terpineol;
  • Rj, R 2 and R 3 are each independently of one another hydrogen, hydroxy, halogen or C r C 6 alkoxy, typically benzyl alcohol, 2,4-dichlorobenzyl alcohol, phenoxyethanol, l-phenoxy-2-propanol (phenoxyisopropanol) and cinnamyl alcohol;
  • Rj and R 2 are each independently of the other hydrogen, C r C 12 alkyl, C 2 -C 12 alkenyl, Cj-Cgalkanoyl, C 3 -C 18 alkenoyl, R 3 -(OCH-CH 2 -)jT 5 o-, wherein
  • R 3 is hydrogen, C r C 1 alkyl or C ⁇ -C ⁇ alkenyl
  • R 4 is hydrogen or -CH 3 , and -(CH 2 -CH-0) ⁇ 3 ⁇ -CH 2 -CH- .
  • All organic acids mentioned under (b) may also be obtained in the form of their water-soluble salts, such as the alkali metal salts, preferably the sodium or potassium salts or the amine(NR ⁇ R 2 R 3 ) salts, wherein
  • R j , R 2 and R 3 are each independently of one another hydrogen
  • R j , R 2 and R 3 together with the linking nitrogen atom, are unsubstituted or
  • Component (b) can consist of only one compound of subclass (bj) or also of mixtures of one or more than one compound of subclass (b ⁇ ), also together with components of further subclasses. Preferably a combination of one or more than one compound of subclass (bj) and one or more than one compound of subclass (b 2 ) is used.
  • Particularly preferred in this connection is a combination of cumene sulfonate and citric acid monohydrate.
  • Suitable components (c) are anionic, nonionic or zwitterionic and amphoteric synthetic, surface-active substances.
  • Suitable anionic surface-active substances are:
  • - sulfates typically fatty alcohol sulfates, which contain 8 to 18 carbon atoms in the alkyl chain, e.g. sulfated lauryl alcohol;
  • - fatty alcohol ether sulfates typically the acid esters or the salts thereof of a polyadduct of 2 to 30 mol of ethylene oxide with 1 mol of a C 8 -C 22 fatty alcohol;
  • alkali metal salts, ammonium salts or amine salts of C 8 -C 20 f att y acids which are termed soaps, typically coconut fatty acid;
  • alkylamine sulfates typically monoethanolamine lauryl sulfate
  • alkane sulfonates containing 8 to 20 carbon atoms in the alkyl chain, e.g. dodecyl sulfonate;
  • sulfosuccinic acid derivatives typically alkyl sulfosuccinates, alkyl ether sulfosuccinates or alkyl sulfosuccinamide derivatives;
  • X is hydrogen, C r C 4 alkyl or -COO M + ,
  • Y is hydrogen or - alkyl
  • Z is -(CH 2 ) m 1 -
  • ⁇ I is an integer from 6 to 18, and
  • M is an alkali metal ion or an amine ion; alkyl ether carboxylates and alkylaryl ether carboxylates of formula
  • X is a radical
  • R is hydrogen or C j - alkyl, Y i s -(CHCHO T30-,
  • 0-M + A is -(CH ) — COO M + or " y O M + m 2 is 1 to 6, and
  • M is an alkali metal cation or an amine cation.
  • the anionic surfactants used may furthermore be fatty acid methyl taurides, alkylisothionates, fatty acid polypeptide condensates and fatty alcohol phosphoric acid esters.
  • the alkyl radicals in these compounds preferably contain 8 to 24 carbon atoms.
  • the anionic surfactants arc usually obtained in the form of their water-soluble salts, such as the alkali metal, ammonium or amine salts.
  • Typical examples of such salts are lithium, sodium, potassium, ammonium, trie thy lamine, ethanolamine, diethanolamine or triethanolamine salts. It is preferred to use the sodium or potassium salts or the ammonium-(NR ] R 2 R 3 ) salts, wherein R j , R 2 and R 3 are each independently of one another hydrogen, C ⁇ -C 4 alkyl or C r C 4 hydroxyalkyl.
  • Very particularly preferred anionic surfactants in the novel formulation are monoethanolamine lauryl sulfate or the alkali metal salts of fatty alcohol sulfates, preferably the sodium lauryl sulfate and the reaction product of 2 to 4 mol of ethylene oxide and sodium lauryl ether sulfate.
  • Suitable zwitterionic and amphoteric surfactants are C -C 18 betaines, C 8 -C 18 sulfobetaines, C 8 -C 4 alkylamido-C 1 -C alkylenebetaines, imidazoline carboxylates, alkylamphocarboxy carboxylic acids, alkylamphocarboxylic acids (e.g. lauroamphoglycinate) and N-alkyl- ⁇ - aminopropionates or N-alkyl- ⁇ -iminodipropionates. It is preferred to use the C 1 o-C 2 oalkylamido-C 1 -C 4 alkylenebetaines and, more particularly, cocoamidopropylbetaine.
  • Nonionic surfactants are typically derivatives of the adducts of propylene oxide/ethylene oxide having a molecular weight of 1000 to 15000, fatty alcohol ethoxylates (1-50 EO), alkylphenol polyglycol ethers (1-50 EO), ethoxylated carbohydrates, fatty acid glycol partial esters, typically diethylene glycol monostearate, fatty acid alkanolamides and fatty acid dialkanolamides, fatty acid alkanolamide ethoxylates and fatty acid amine oxides.
  • component (c) may furthermore be used the salts of saturated and unsaturated Cg- ⁇ fatty acids, either by themselves, in admixture with each other or in admixture with the other surface-active substances cited for component (c).
  • Illustrative examples of these fatty acids are typically capric, lauric, myristic, palmitic, stearic, arachic, behenic, dodecenoic, tetradecenoic, octadecenoic, oleic, eicosanic and erucic acid, as well as the technical mixtures of such acids, typically coconut fatty acid.
  • acids may be obtained in the form of salts, suitable cations being alkali metal cations such as sodium and potassium cations, metal atoms such as zinc atoms and aluminium atoms or nitrogen-containing organic compounds of sufficient alkalinity, typically amines or ethoxylated amines.
  • suitable cations being alkali metal cations such as sodium and potassium cations, metal atoms such as zinc atoms and aluminium atoms or nitrogen-containing organic compounds of sufficient alkalinity, typically amines or ethoxylated amines.
  • suitable cations being alkali metal cations such as sodium and potassium cations, metal atoms such as zinc atoms and aluminium atoms or nitrogen-containing organic compounds of sufficient alkalinity, typically amines or ethoxylated amines.
  • Suitable components (d) are dihydric alcohols, preferably those containing 2 to 6 carbon atoms in the alkylene radical, typically ethylene glycol, 1,2- or 1,3-propanediol, 1,3-, 1,4- or 2,3-butanediol, 1,5-pentanediol and 1,6-hexanediol. 1,2-propanediol (propylene glycol) is preferred.
  • Component (e) is preferably ethanol, n-propanol and isopropanol, or a mixture of these alcohols. Components (d) and (e) may also be obtained in admixture with each other.
  • the pH of the novel formulation is 3 to 10, preferably 3,5 to 5,5.
  • novel formulations obtained as soap or syndet solutions may additionally comprise customary additives, typically sequestrants, dyes, perfume oils, thickeners or solidifiers (consistency regulators), emollients, UV absorbers, skin-protection agents, antioxidants, additives which improve the mechanical properties, such as dicarboxylic acids and/or Al, Zn, Ca, Mg salts of C 1 -C 2 fatty acids and, if desired, preservatives.
  • customary additives typically sequestrants, dyes, perfume oils, thickeners or solidifiers (consistency regulators), emollients, UV absorbers, skin-protection agents, antioxidants, additives which improve the mechanical properties, such as dicarboxylic acids and/or Al, Zn, Ca, Mg salts of C 1 -C 2 fatty acids and, if desired, preservatives.
  • Soap formulations of the invention can be prepared by mixing components (a) and (b) and, optionally, (c), (d) and (e), in any order, with the requisite amount of water and stirring the mixture to homogeneity.
  • the mixture is bulked to 100% with mains water or deinonised water. This procedure is a purely physical procedure. Accordingly, there is no chemical reaction of the individual components.
  • the novel soap formulations can be applied thereto in dilute or undilute form, suitably in an amount of at least 2 ml, preferably in the undilute form, for hand disinfection.
  • the invention is illustrated by the following Examples. Parts and percentages are by weight.
  • 0.5 % propylene glycol are stirred to homogeneity and about 90% of the requisite water is then added.
  • the pH is adjusted to 4.0 with monoethanolamine.
  • Deionised water is then added to the solution to make up a total of 100 parts.
  • the pH is checked again and, if necessary, monoethanolamine is added to adjust the pH to 4.0.
  • 1.0 % propylene glycol are stirred to homogeneity and about 90% of the requisite water is then added.
  • the pH is adjusted to 4.0 with monoethanolamine.
  • Deionised water is then added to the solution to make up a total of 100 parts.
  • the pH is checked again and, if necessary, monoethanolamine is added to adjust the pH to 4.0.
  • 0.019 % NaOH are stirred to homogeneity and about 90% of the requisite water is then added.
  • the pH is adjusted to 9.1 with monoethanolamine.
  • Deionised water is then added to the solution to make up a total of 100 parts.
  • the pH is checked again and, if necessary, monoethanolamine is added to adjust the pH to 9.1.
  • Example 5 Test of the microbicidal activitiv of the novel formulations The microbicidal activity (in decimal logarithms) of the novel formulations according to Examples 1 to 4 is determined with a suspension test. This test is used to assess the bactericidal activity of water-soluble antiseptics, disinfectants and of liquid soaps. The test consists in seeding the test product in selected dilutions with the test bacillus. After a certain contact time, aliquots is taken and the number of surviving bacilli is determined. The difference between the number of the bacilli added and the number of the surviving bacilli is expressed as bacilli reduction in decimal logarithms. The concentration is 90%, the contact time is 30 seconds.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
EP95929862A 1994-08-25 1995-08-14 Surface-active formulations Withdrawn EP0777716A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2610/94 1994-08-25
CH261094 1994-08-25
PCT/EP1995/003210 WO1996006152A2 (en) 1994-08-25 1995-08-14 Surface-active formulations

Publications (1)

Publication Number Publication Date
EP0777716A2 true EP0777716A2 (en) 1997-06-11

Family

ID=4237644

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95929862A Withdrawn EP0777716A2 (en) 1994-08-25 1995-08-14 Surface-active formulations

Country Status (12)

Country Link
EP (1) EP0777716A2 (es)
JP (1) JPH10504591A (es)
AU (1) AU3345195A (es)
BG (1) BG101306A (es)
BR (1) BR9508767A (es)
CA (1) CA2196774A1 (es)
CZ (1) CZ55597A3 (es)
FI (1) FI970741A (es)
HU (1) HUT77706A (es)
MX (1) MX9701417A (es)
SK (1) SK24597A3 (es)
WO (1) WO1996006152A2 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1201229B1 (en) * 1996-06-04 2011-11-09 Basf Se Concentrated liquid formulations comprising a microbicidally active ingredient
US5955408A (en) * 1996-07-10 1999-09-21 Steris Inc. Triclosan skin wash with enhanced efficacy
BR9603085A (pt) * 1996-07-12 1998-05-05 Cosmeticos Natural Ind Com Sabonete antisséptico líquido para cuidado da pele
US6214363B1 (en) 1997-11-12 2001-04-10 The Procter & Gamble Company Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria
US6183763B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
US6190675B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria
US6197315B1 (en) 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US6287577B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria
US6190674B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Liquid antimicrobial cleansing compositions
US6183757B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing
US5968539A (en) * 1997-06-04 1999-10-19 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria
US6284259B1 (en) 1997-11-12 2001-09-04 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria
US6210695B1 (en) 1997-06-04 2001-04-03 The Procter & Gamble Company Leave-on antimicrobial compositions
US6287583B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Low-pH, acid-containing personal care compositions which exhibit reduced sting
US6861397B2 (en) * 1999-06-23 2005-03-01 The Dial Corporation Compositions having enhanced deposition of a topically active compound on a surface
US6107261A (en) * 1999-06-23 2000-08-22 The Dial Corporation Compositions containing a high percent saturation concentration of antibacterial agent
BR0011860A (pt) * 1999-06-23 2002-04-30 Dial Corp Composições antibacterianas e processo para redução de uma população de bactérias sobre uma superfìcie
AU5471000A (en) * 1999-06-23 2001-01-09 Dial Corporation, The Antibacterial compositions
DE19957739A1 (de) * 1999-12-01 2001-06-28 Henkel Ecolab Gmbh & Co Ohg Handwaschlotion für wiederbefüllbare Schaumerzeugungsvorrichtung
ES2259654T3 (es) * 2000-06-21 2006-10-16 Ciba Specialty Chemicals Holding Inc. Preparados tensoactivos.
US8329685B1 (en) * 2000-07-19 2012-12-11 North West University Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
CN1293177C (zh) 2000-12-14 2007-01-03 西巴特殊化学品控股有限公司 表面活性组合物
US6616922B2 (en) 2001-03-27 2003-09-09 The Dial Corporation Antibacterial compositions
US6977082B2 (en) * 2001-03-29 2005-12-20 The Dial Corporation High efficacy antibacterial compositions having enhanced esthetic and skin care properties
US6794351B2 (en) 2001-04-06 2004-09-21 Kimberly-Clark Worldwide, Inc. Multi-purpose cleaning articles
AU2002308579B2 (en) 2001-05-01 2004-07-15 The Dial Corporation Method for reducing malodors in hydrotropic compositions
GB2393907A (en) * 2002-10-12 2004-04-14 Reckitt Benckiser Inc Antimicrobial hard surface cleaner
US20080267904A1 (en) * 2004-12-09 2008-10-30 The Dial Corporation Compositions Having A High Antiviral And Antibacterial Efficacy
JP5269776B2 (ja) 2006-06-14 2013-08-21 チバ ホールディング インコーポレーテッド 抗菌組成物
US20080026974A1 (en) 2006-07-27 2008-01-31 Barnhart Ronald A Antimicrobial hand wash
EP2708593A1 (en) * 2012-09-14 2014-03-19 The Procter & Gamble Company Fabric care composition
EP2727991A1 (en) * 2012-10-30 2014-05-07 The Procter & Gamble Company Cleaning and disinfecting liquid hand dishwashing detergent compositions
US10952949B2 (en) 2015-04-23 2021-03-23 The Procter And Gamble Company Concentrated personal cleansing compositions
US11202746B2 (en) 2015-04-23 2021-12-21 The Procter And Gamble Company Concentrated personal cleansing compositions and methods
WO2016172482A1 (en) 2015-04-23 2016-10-27 The Procter & Gamble Company Concentrated personal cleansing compositions and methods
EP3285889B1 (en) 2015-04-23 2020-07-22 The Procter and Gamble Company Concentrated personal cleansing compositions and uses
US11185486B2 (en) 2016-10-21 2021-11-30 The Procter And Gamble Company Personal cleansing compositions and methods
US11179301B2 (en) 2016-10-21 2021-11-23 The Procter And Gamble Company Skin cleansing compositions and methods
US10675231B2 (en) 2017-02-17 2020-06-09 The Procter & Gamble Company Packaged personal cleansing product
US10806686B2 (en) 2017-02-17 2020-10-20 The Procter And Gamble Company Packaged personal cleansing product

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1467619A1 (de) * 1965-11-27 1969-02-13 Henkel & Cie Gmbh Farbstabile,Desinfektionsmittel enthaltende fluessige Wasch-,Reinigungs- und Spuelmittel
GB1266060A (es) * 1969-09-12 1972-03-08
BE768041R (fr) * 1971-06-03 1971-12-03 Ciba Geigy Ag Composition pour combattre les
IT974496B (it) * 1971-12-13 1974-06-20 Basf Wyandotte Corp Perfezionamento nelle composizioni detergenti in particolare per il lavaggio di autovetture in impianti automatici o semiautoma tici
GB1539031A (en) * 1975-02-22 1979-01-24 Beecham Group Ltd Pharmaceutical compositions
LU78554A1 (de) * 1977-11-21 1979-06-13 Ciba Geigy Ag Verfahren zur herstellung neuer 3-hydroxydiphenylaether
DE3117792C2 (de) * 1981-05-06 1990-08-23 Schülke & Mayr GmbH, 2000 Norderstedt Die Verwendung einer wässrigen Lösung von Alkoholen, Phenolen und oberflächenaktiven Stoffen als viruzides Mittel
DE3723990A1 (de) * 1986-07-23 1988-02-04 Ciba Geigy Ag Mikrobizide zubereitung
AU3001889A (en) * 1988-02-17 1989-08-17 Ciba-Geigy Ag Antimicrobial soap composition
US4832861A (en) * 1988-05-27 1989-05-23 Lever Brothers Company Soap compositions of enhanced antimicrobial effectiveness
JPH05279693A (ja) * 1992-04-02 1993-10-26 Shin Etsu Chem Co Ltd 抗菌性洗浄剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9606152A2 *

Also Published As

Publication number Publication date
SK24597A3 (en) 1997-08-06
BR9508767A (pt) 1997-11-11
BG101306A (en) 1997-09-30
WO1996006152A2 (en) 1996-02-29
JPH10504591A (ja) 1998-05-06
FI970741A0 (fi) 1997-02-21
CA2196774A1 (en) 1996-02-29
HUT77706A (hu) 1998-07-28
CZ55597A3 (en) 1997-06-11
WO1996006152A3 (en) 1996-05-02
MX9701417A (es) 1997-05-31
FI970741A (fi) 1997-02-21
AU3345195A (en) 1996-03-14

Similar Documents

Publication Publication Date Title
EP0777716A2 (en) Surface-active formulations
EP0777717A2 (en) Surface-active formulations
TW304206B (es)
US8232305B2 (en) Anti-microbial compositions
JP4976184B2 (ja) 液体洗浄剤組成物
EP1201229A1 (en) Concentrated liquid formulations comprising a microbicidally active ingredient
NZ321730A (en) Germicidal dishwashing detergent compositions
SK71197A3 (en) A composition for hard surfaces cleaning and disinfection method of inanimate surfaces
EP0197968A1 (en) ANTISEPTIC DETERGENT COMPOSITIONS.
US4456543A (en) Bisbiguanide based antibacterial cleansing products
NZ527650A (en) Preservative blends containing quaternary ammonium compounds
EP0259249A2 (de) Mikrobizide Zubereitung
US11975085B2 (en) Non-soap liquid cleanser composition comprising anionic surfactant, caprylic acid, and non-ionic molecule
EP1167503B1 (en) Surface-active preparations
JP5500835B2 (ja) 除菌・抗菌剤組成物
EP1551359B1 (en) Surface treatment
JPS6345217A (ja) 殺菌剤組成物
JP2002212007A (ja) 殺菌性組成物
JPH10506116A (ja) カルボン酸アミドの抗菌活性を向上するための界面活性剤の使用
CA2582797C (en) Concentrated liquid formulations comprising a microbicidally active ingredient
CA2252555C (en) Concentrated liquid formulations comprising a microbicidally active ingredient
JP2013091629A (ja) 殺菌性組成物
PL99061B1 (pl) Srodek myjaco-czyszczacy

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970128

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 19990702

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19991113